ACHIEVE LIFE SCIENCES, INC. — Form 8-K
Filed August 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Achieve Life Sciences, Inc. (market cap ~$104M) entered into an Open Market Sale Agreement with Jefferies LLC on August 14, 2026, authorizing the sale of up to $150,000,000 in common stock on an at-the-market basis. The company may issue shares periodically through Jefferies at market prices subject to a floor price set by the company, with Jefferies receiving a 3% selling commission. The agreement is effective until August 14, 2027 (per the Registration Statement expiration date January 29, 2029) unless earlier terminated, and shares will be registered under Form S-3.
Why this rating
At ~144% of current market cap, this ATM authorization is material and dilutive in scale, enabling significant capital raises. However, ATMs are routine equity financing tools; actual proceeds depend on future execution. No imminent sales announced—significance is moderate-to-high due to size relative to company but neutral impact pending actual deployment.
Extracted items
- 2.02 results / earnings
- 8.01 other event
- 9.01 exhibits
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.